HDDC2 Knockout Jurkat Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population in which the HDDC2 gene has been disrupted in the Jurkat T lymphoblast background. This polyclonal pool, comprising a heterogeneous mixture of edited cells, provides a robust loss-of-function model without the clonal selection bottlenecks associated with single-cell-derived lines. The knockout product is generated using CRISPR/Cas9-mediated gene disruption, ensuring broad utility for studying HDDC2-dependent processes in a physiologically relevant T-cell context.
Jurkat cells are an immortalized human T lymphocyte line originally derived from the peripheral blood of a 14-year-old male with acute T-cell leukemia. These cells serve as a widely used model for T-cell signaling, apoptosis, and HIV research due to their retention of key lymphocyte features, including antigen receptor signaling and susceptibility to viral infection. The Jurkat background is particularly suited for investigating nucleotide metabolism and DNA damage responses within the immune system, offering a tractable system to dissect the role of HDDC2 in T-cell homeostasis.
HDDC2 encodes a predicted phosphohydrolase that likely hydrolyzes deoxynucleoside triphosphates (dNTPs), thereby modulating intracellular dNTP pool sizes and influencing DNA replication fidelity. This enzymatic function places HDDC2 at the intersection of nucleotide metabolism and the DNA damage response. The gene is activated downstream of p53 and DNA damage signaling, and its activity contributes to the regulation of dNTP pools and DNA synthesis. HDDC2 shares functional relationships with SAMHD1, a known dNTPase that restricts retroviral replication, and operates within a signaling network that includes the ATR and CHK1 kinases. By controlling dNTP availability, HDDC2 helps maintain genome stability and shapes cellular responses to replication stress and viral challenge.
In Jurkat T cells, HDDC2 knockout disrupts nucleotide homeostasis, potentially leading to altered dNTP levels that compromise DNA replication fidelity and activate DNA damage checkpoints. This perturbation makes the knockout cells a powerful system for dissecting how dNTP imbalances affect T-cell proliferation, survival, and genomic integrity under genotoxic stress or during viral infection. The model also enables investigation of innate immune pathways that sense aberrant nucleotides, providing insights into the interplay between metabolism and immune function in a T lymphocyte background.
These HDDC2 knockout polyclonal cells are ideally suited for nucleotide metabolism studies, DNA damage response analysis, and viral restriction factor research. Typical experimental applications include quantification of dNTP pools, cell cycle profiling, and assessment of replication stress markers such as ??H2AX by immunofluorescence. Functional assays measuring viral infectivity or T-cell activation can further elucidate HDDC2??s role in host?Cpathogen interactions. Validation endpoints may involve Western blotting for HDDC2 protein levels and RT-qPCR for transcript analysis. For additional information or to explore how this polyclonal knockout model can advance your research, please contact Ascent Research.
